Integrons in the development of antimicrobial resistance: critical review and perspectives.
antibiotic stewardship
antimicrobial resistance
horizontal gene transfer
integrons
pathogenicity
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2023
2023
Historique:
received:
31
05
2023
accepted:
14
08
2023
medline:
18
9
2023
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
epublish
Résumé
Antibiotic resistance development and pathogen cross-dissemination are both considered essential risks to human health on a worldwide scale. Antimicrobial resistance genes (AMRs) are acquired, expressed, disseminated, and traded mainly through integrons, the key players capable of transferring genes from bacterial chromosomes to plasmids and their integration by integrase to the target pathogenic host. Moreover, integrons play a central role in disseminating and assembling genes connected with antibiotic resistance in pathogenic and commensal bacterial species. They exhibit a large and concealed diversity in the natural environment, raising concerns about their potential for comprehensive application in bacterial adaptation. They should be viewed as a dangerous pool of resistance determinants from the "One Health approach." Among the three documented classes of integrons reported viz., class-1, 2, and 3, class 1 has been found frequently associated with AMRs in humans and is a critical genetic element to serve as a target for therapeutics to AMRs through gene silencing or combinatorial therapies. The direct method of screening gene cassettes linked to pathogenesis and resistance harbored by integrons is a novel way to assess human health. In the last decade, they have witnessed surveying the integron-associated gene cassettes associated with increased drug tolerance and rising pathogenicity of human pathogenic microbes. Consequently, we aimed to unravel the structure and functions of integrons and their integration mechanism by understanding horizontal gene transfer from one trophic group to another. Many updates for the gene cassettes harbored by integrons related to resistance and pathogenicity are extensively explored. Additionally, an updated account of the assessment of AMRs and prevailing antibiotic resistance by integrons in humans is grossly detailed-lastly, the estimation of AMR dissemination by employing integrons as potential biomarkers are also highlighted. The current review on integrons will pave the way to clinical understanding for devising a roadmap solution to AMR and pathogenicity. Graphical AbstractThe graphical abstract displays how integron-aided AMRs to humans: Transposons capture integron gene cassettes to yield high mobility integrons that target res sites of plasmids. These plasmids, in turn, promote the mobility of acquired integrons into diverse bacterial species. The acquisitions of resistant genes are transferred to humans through horizontal gene transfer.
Identifiants
pubmed: 37720149
doi: 10.3389/fmicb.2023.1231938
pmc: PMC10500605
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1231938Informations de copyright
Copyright © 2023 Bhat, Mir, Qadri, Dhiman, Almilaibary, Alkhanani and Mir.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2021 Dec 29;16(12):e0261970
pubmed: 34965260
J Microbiol. 2009 Feb;47(1):19-27
pubmed: 19229487
FEMS Microbiol Lett. 2006 Jan;254(1):75-80
pubmed: 16451182
Curr Top Microbiol Immunol. 2013;366:19-36
pubmed: 22692831
J Bacteriol. 2015 Jul;197(13):2171-2178
pubmed: 25897031
Nat Rev Microbiol. 2022 May;20(5):257-269
pubmed: 34737424
Nat Genet. 2004 Jul;36(7):760-6
pubmed: 15208628
Environ Int. 2019 Mar;124:145-152
pubmed: 30641258
J Antimicrob Chemother. 2004 Mar;53(3):518-21
pubmed: 14749340
J Med Microbiol. 2006 Dec;55(Pt 12):1685-1691
pubmed: 17108272
Antimicrob Agents Chemother. 2000 May;44(5):1315-21
pubmed: 10770768
J Antimicrob Chemother. 2010 Mar;65(3):474-8
pubmed: 20071364
FEMS Microbiol Rev. 2011 Sep;35(5):912-35
pubmed: 21729108
FEMS Microbiol Lett. 2001 Feb 5;195(1):59-65
pubmed: 11166996
Front Microbiol. 2017 Sep 27;8:1891
pubmed: 29021787
Gut Pathog. 2016 Aug 30;8(1):40
pubmed: 27582900
J Basic Microbiol. 2009 Dec;49(6):572-8
pubmed: 19810047
J Infect Dev Ctries. 2010 May 01;4(4):207-12
pubmed: 20440057
J Antimicrob Chemother. 2005 Mar;55(3):371-4
pubmed: 15705645
Lancet Infect Dis. 2013 Feb;13(2):155-65
pubmed: 23347633
EMBO J. 2005 Dec 21;24(24):4356-67
pubmed: 16341091
Trends Microbiol. 2023 May;31(5):432-434
pubmed: 35140037
Antimicrob Agents Chemother. 2015 Oct;59(10):6670-2
pubmed: 26239988
J Bacteriol. 2008 Jul;190(14):5095-100
pubmed: 18487337
Curr Pharm Biotechnol. 2021;22(4):480-500
pubmed: 32600226
J Bacteriol. 1999 Nov;181(21):6844-9
pubmed: 10542191
PLoS One. 2011;6(10):e26041
pubmed: 22016806
Mol Microbiol. 1999 Aug;33(3):449-56
pubmed: 10577069
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
Adv Microb Physiol. 1979;19:245-331
pubmed: 121792
Nat Microbiol. 2017 Jan 30;2:16270
pubmed: 28134918
Microbiologyopen. 2021 Oct;10(5):e1219
pubmed: 34713606
J Clin Microbiol. 2003 Dec;41(12):5407-13
pubmed: 14662918
J Antimicrob Chemother. 2006 Aug;58(2):297-304
pubmed: 16782741
Vet Res. 2001 May-Aug;32(3-4):243-59
pubmed: 11432416
Int J Antimicrob Agents. 2006 Mar;27(3):267-70
pubmed: 16455233
Clin Microbiol Infect. 2011 May;17(5):714-8
pubmed: 21521411
Curr Pharm Biotechnol. 2022;23(14):1704-1720
pubmed: 34951359
Nat Biotechnol. 2018 Nov;36(10):996-1004
pubmed: 30148503
Environ Pollut. 2023 Jan 1;316(Pt 2):120601
pubmed: 36351483
J Antimicrob Chemother. 2005 Dec;56(6):1019-24
pubmed: 16239286
Antimicrob Agents Chemother. 2003 Nov;47(11):3640-3
pubmed: 14576136
Int J Environ Res Public Health. 2013 Jun 28;10(7):2643-69
pubmed: 23812024
Sci Rep. 2022 May 4;12(1):7296
pubmed: 35508512
J Antimicrob Chemother. 2008 Aug;62(2):296-302
pubmed: 18456652
J Ethnopharmacol. 2022 Jun 12;291:115046
pubmed: 35167935
Environ Sci Technol. 2016 Jan 5;50(1):420-7
pubmed: 26650334
Environ Health Prev Med. 2015 Jul;20(4):243-52
pubmed: 25921603
J Bacteriol. 2001 Jan;183(1):235-49
pubmed: 11114922
Mol Gen Mikrobiol Virusol. 2003;(4):3-10
pubmed: 14664155
J Appl Microbiol. 2002;92(5):992-1004
pubmed: 11972706
APMIS Suppl. 1998;84:37-42
pubmed: 9850680
Br J Pharmacol. 2008 Mar;153 Suppl 1:S347-57
pubmed: 18193080
Am Nat. 2004 Jul;164(1):1-12
pubmed: 15266366
Environ Microbiol. 2019 May;21(5):1567-1574
pubmed: 30724441
Elife. 2021 Feb 26;10:
pubmed: 33634790
Iran J Basic Med Sci. 2021 Feb;24(2):136-142
pubmed: 33953851
J Biomed Nanotechnol. 2021 Dec 1;17(12):2298-2318
pubmed: 34974855
Res Microbiol. 2001 Jun;152(5):421-30
pubmed: 11446510
Annu Rev Genet. 2010;44:141-66
pubmed: 20707672
Ann N Y Acad Sci. 1999 May 18;870:68-80
pubmed: 10415474
J Law Med Ethics. 2015 Summer;43 Suppl 3:38-45
pubmed: 26243242
Onderstepoort J Vet Res. 2012 Jun 20;79(2):492
pubmed: 23327380
Gene. 2014 Jul 1;544(1):75-82
pubmed: 24768721
Emerg Infect Dis. 2003 Jul;9(7):822-6
pubmed: 12890322
PLoS Genet. 2018 Dec 21;14(12):e1007862
pubmed: 30576310
Pharmaceuticals (Basel). 2023 Jun 15;16(6):
pubmed: 37375828
FEMS Microbiol Rev. 2018 Jan 1;42(1):
pubmed: 29069382
FEMS Microbiol Rev. 2009 Jul;33(4):757-84
pubmed: 19416365
Mob Genet Elements. 2012 Sep 1;2(5):211-223
pubmed: 23550063
J Antimicrob Chemother. 2015 Nov;70(11):3000-3
pubmed: 26209313
Commun Biol. 2021 Aug 9;4(1):946
pubmed: 34373573
Microb Genom. 2022 Mar;8(3):
pubmed: 35298369
Mol Microbiol. 1995 Feb;15(4):593-600
pubmed: 7783631
Annu Rev Microbiol. 1969;23:69-136
pubmed: 4899081
J Bacteriol. 2003 Feb;185(3):918-28
pubmed: 12533467
Antimicrob Agents Chemother. 2003 Apr;47(4):1427-9
pubmed: 12654684
Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6427-6440
pubmed: 36121484
Int J Antimicrob Agents. 2016 Oct;48(4):431-4
pubmed: 27499434
Microb Pathog. 2017 Aug;109:35-38
pubmed: 28479508
FEMS Microbiol Rev. 2011 Sep;35(5):790-819
pubmed: 21517914
Microbiol Mol Biol Rev. 1999 Sep;63(3):507-22
pubmed: 10477306
Indian J Med Microbiol. 2015 Apr-Jun;33(2):231-6
pubmed: 25865973
J Clin Microbiol. 2009 Jan;47(1):230-4
pubmed: 19020065
Trends Microbiol. 2007 Jul;15(7):301-9
pubmed: 17566739
Nat Rev Microbiol. 2006 Aug;4(8):608-20
pubmed: 16845431
Genes (Basel). 2018 Feb 19;9(2):
pubmed: 29463055
J Infect Dev Ctries. 2010 Jun 30;4(6):412-6
pubmed: 20601796
Microbiome. 2017 Dec 15;5(1):160
pubmed: 29246178
Nucleic Acids Res. 2021 Jun 4;49(10):5654-5670
pubmed: 34048565
Molecules. 2021 May 02;26(9):
pubmed: 34063264
ISME J. 2015 Jun;9(6):1467-76
pubmed: 25679532
J Infect Dis. 2003 Jan 15;187(2):251-9
pubmed: 12552449
Microbiol Spectr. 2015 Apr;3(2):MDNA3-0019-2014
pubmed: 26104695
Curr Drug Targets. 2021;22(12):1424-1436
pubmed: 33371847
Infect Ecol Epidemiol. 2016 Nov 29;6:33703
pubmed: 27906121
Clin Microbiol Rev. 2018 Aug 1;31(4):
pubmed: 30068738
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30003866
Clin Microbiol Rev. 2020 Feb 26;33(2):
pubmed: 32102899
Diagn Microbiol Infect Dis. 2010 Nov;68(3):315-7
pubmed: 20846812
PLoS Pathog. 2012;8(6):e1002778
pubmed: 22719259
Int J Antimicrob Agents. 2014 Oct;44(4):351-3
pubmed: 25130099
Emerg Infect Dis. 2013 Jul;19(7):
pubmed: 23764294
J Antimicrob Chemother. 2021 Dec 24;77(1):213-217
pubmed: 34557914
Br Poult Sci. 2020 Apr;61(2):122-131
pubmed: 31774316
Microbiol Spectr. 2016 Apr;4(2):
pubmed: 27227291
Drug Resist Updat. 2015 Jul-Aug;21-22:41-59
pubmed: 26304792
Ann Clin Microbiol Antimicrob. 2015 Oct 20;14:45
pubmed: 26487554
J Formos Med Assoc. 2013 May;112(5):269-75
pubmed: 23660223
J Antimicrob Chemother. 2010 Aug;65(8):1594-8
pubmed: 20525990
Trends Microbiol. 2020 Jun;28(6):455-464
pubmed: 31948729
J Antimicrob Chemother. 2008 Sep;62(3):469-73
pubmed: 18550679
Sci Rep. 2022 Jul 22;12(1):12547
pubmed: 35869098
Nat Rev Microbiol. 2015 May;13(5):310-7
pubmed: 25817583
Mol Microbiol. 1989 Dec;3(12):1669-83
pubmed: 2560119
Trop Med Infect Dis. 2019 Jan 29;4(1):
pubmed: 30700019
ISME J. 2015 Jun;9(6):1269-79
pubmed: 25500508
BMC Evol Biol. 2013 Jan 22;13:16
pubmed: 23339550
BMJ. 2013 Aug 13;347:f4976
pubmed: 23943753
Osong Public Health Res Perspect. 2014 Aug;5(4):193-8
pubmed: 25379369
Nucleic Acids Res. 2016 Jun 2;44(10):4539-50
pubmed: 27130947
Caspian J Intern Med. 2017 Fall;8(4):311-316
pubmed: 29201324
Science. 2009 May 22;324(5930):1034
pubmed: 19460999
Curr Microbiol. 2011 Mar;62(3):802-6
pubmed: 20976456
Med Chem. 2022;18(10):1109-1121
pubmed: 35507782
Environ Sci Technol. 2017 May 16;51(10):5721-5728
pubmed: 28426231
Braz J Microbiol. 2021 Mar;52(1):363-372
pubmed: 33247398
Methods Mol Biol. 2009;532:103-25
pubmed: 19271181
J Antimicrob Chemother. 2008 Nov;62(5):934-7
pubmed: 18708645
Nat Rev Microbiol. 2014 Mar;12(3):181-96
pubmed: 24509783
Infect Drug Resist. 2014 Jun 20;7:167-76
pubmed: 25018641
Ecotoxicology. 2009 Aug;18(6):652-60
pubmed: 19495963
Microbiology (Reading). 2015 Jul;161(7):1313-37
pubmed: 25901001
Nat Rev Microbiol. 2005 Sep;3(9):711-21
pubmed: 16138099
Mol Biol Rep. 2011 Nov;38(8):5261-79
pubmed: 21258866
Br J Biomed Sci. 2008;65(2):86-9
pubmed: 19055111
FEMS Immunol Med Microbiol. 2010 Apr;58(3):421-5
pubmed: 20030716
Bioinformatics. 2009 Apr 15;25(8):1096-8
pubmed: 19228805
J Bacteriol. 2006 Aug;188(16):5722-30
pubmed: 16885440
Front Microbiol. 2020 Dec 02;11:605952
pubmed: 33343549
Nature. 2000 May 18;405(6784):299-304
pubmed: 10830951
PLoS Genet. 2010 Oct 21;6(10):e1001165
pubmed: 20975940
J Bacteriol. 2002 Jun;184(11):3017-26
pubmed: 12003943
Microbiol Mol Biol Rev. 2014 Jun;78(2):257-77
pubmed: 24847022
Appl Microbiol Biotechnol. 2014 Jun;98(11):5195-204
pubmed: 24615381